For the approximately one-third of transcatheter aortic valve replacement (TAVR) candidates whose iliofemoral disease makes conventional access difficult, CoreValve implantation via a subclavian ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window HOUSTON -- ...
Patients with aortic stenosis who undergo transcatheter aortic valve replacement via the subclavian and femoral arteries have equivalent clinical outcomes at 30 days and 1 year, according to a new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback